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Chagas disease in the chronic phase may develop into cardiac and/or digestive forms. The pathogenesis of the 
disease is not yet clear and studies have been carried out to elucidate the role of parasite persistence in affected 
organs. The aim of this study was to detect and quantify Trypanosoma cruzi in paraffin-embedded tissue samples 
from chronic patients using NPCR (nested polymerase chain reaction) and QPCR (quantitative polymerase chain 
reaction) methods. These results were correlated to anatomopathological alterations in the heart and gastrointes-
tinal tract (GIT). Of the 23 patients studied, 18 presented the cardiac form and five presented the cardiodigestive 
form of Chagas disease. DNA samples were randomly isolated from formalin-fixed paraffin-embedded sections of 
heart and GIT tissue of 23 necropsies and were analyzed through NPCR amplification. T. cruzi DNA was detected 
by NPCR in 48/56 (85.7%) heart and 35/42 (83.3%) GIT samples from patients with the cardiac form. For patients 
with the cardiodigestive form, NPCR was positive in 12/14 (85.7%) heart and in 14/14 (100%) GIT samples. QPCR, 
with an efficiency of 97.6%, was performed in 13 samples (11 from cardiac and 2 from cardiodigestive form) identi-
fied previously as positive by NPCR. The number of T. cruzi copies was compared to heart weight and no statistical 
significance was observed. Additionally, we compared the number of copies in different tissues (both heart and GIT) 
in six samples from the cardiac form and two samples from the cardiodigestive form. The parasite load observed 
was proportionally higher in heart tissues from patients with the cardiac form. These results show that the presence 
of the parasite in tissues is essential to Chagas disease pathogenesis.
Key words: Trypanosoma cruzi - real-time PCR - nested PCR - Chagas disease
The chagasic infection caused by the Trypanosoma 
cruzi protozoan may have a different evolution based 
on the circumstance and situation. The parasite-host 
interaction is dynamic and results from several fac-
tors related to the trypanosome (strain, virulence and 
inoculation), the human host (age, gender and genetic 
profile) and the environment. T. cruzi infection affects 
between 12-14 million people and approximately 25% 
of the Latin American population is at risk of contract-
ing Chagas disease (WHO 2002).
It is believed that there are two phases of the dis-
ease: the acute phase and the chronic phase. The acute 
phase is characterized by parasites found throughout the 
body, replicating within macrophages and a variety of 
other host cells, especially cardiac muscle cells. It is his-
topathologically characterized by inflammatory infiltra-
tion and tissue necrosis (Soares & Ribeiro dos Santos 
1999). Following an acute infection, the chronic phase is 
characterized by a variable clinical course ranging from 
absence of symptoms to severe cardiac and/or gastroin-
testinal involvement (Macedo et al. 2002). 
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According to Köberle (1968), the number of parasites 
decreases from the acute to the chronic phase, both in the 
blood and in tissues. The period when no clinical symp-
toms or significant histopathological lesions are found is 
called the indeterminate form and can last up to 20 years. 
The typical chronic form of Chagas disease affects the 
heart in approximately 25% of the cases. Variable degrees 
of cardiac hypertrophy and dilatation are found with or 
without apical aneurysm. The other clinical form consists 
of dilatation of digestive organs, such as the oesophagus 
and the colon, as a consequence of neuronal destruction of 
the gastrointestinal tract (GIT) (Köberle et al. 1983).
The presence of T. cruzi close to the disease sites 
strengthens the hypothesis of parasite persistence in in-
fected tissues, which is based on experimental results 
obtained through molecular biology techniques and 
decreased parasite load following specific treatments 
(Tarleton 2001). In 1993, Jones et al. (1993) detected T. 
cruzi DNA in the heart of autopsied patients by hybrid-
ized polymerase chain reaction (PCR), indicating that 
the persistence of parasite DNA is crucial to the disease 
pathogenesis and that the inflammatory process is as-
sociated with the presence of T. cruzi DNA in infected 
tissues (Vago et al. 1996).
Adad et al. (1991) reported the finding of chronic 
inflammatory processes in the oesophagus of asymp-
tomatic chronic chagasic patients and in those present-
ing megaoesophagus. These findings were confirmed 
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by PCR, which amplified T. cruzi DNA both in the 
oesophagus of patients (Lages-Silva et al. 2001, Elias 
et al. 2003, Vago et al. 2003) and in infected murine 
cardiac tissue (Lane et al. 2003). 
The PCR quantification method is based on the use 
of a fluorescent probe (TaqMan®) or fluorescent mol-
ecules (SYBR®green). This technique consists of real-
time monitoring of the quantity of DNA being assessed 
as numerical values or the number of copies of DNA 
units. Recently, Duffy et al. (2009) used quantitative 
PCR (QPCR) to evaluate the parasitic load in children 
with Chagas disease, in patients under specific treat-
ment and in cases of heart transplantation.
Real-time T. cruzi PCR quantification was described 
by Cummings and Tarleton in 2003. The examination of 
infected experimental models revealed sensitive and ac-
curate quantification of parasites in host tissues, with ki-
netoplastDNA and satellite DNA target fragments, both 
repetitive regions and in a great number of copies in the 
T. cruzi genome. It was shown that the detected DNA is 
derived from the persistence of the parasite in the affect-
ed tissues and not from DNA persistence over long peri-
ods of time. Piron et al. (2007) used nested PCR (NPCR) 
and real-time techniques to detect and quantify T. cruzi 
in blood samples of chagasic patients, obtaining a similar 
positivity rate to results obtained by Marcon et al. (2002). 
The real-time PCR technique was also employed to de-
tect T. cruzi in the amniotic fluid of mothers with Chagas 
disease (Virreira et al. 2006) and to subtype T. cruzi I 
and II in infected tissues by means of the difference in 
primer annealing temperatures. The real-time PCR strat-
egy demonstrated that T. cruzi II is the causative agent of 
the tissue lesions of Chagas disease (Freitas et al. 2005). 
Higuchi et al. (2003) emphasized a significant as-
sociation between the presence of T. cruzi antigens in 
the heart and severe or moderate inflammation, which 
results from a close interaction between the host and the 
parasite, causing different clinical cardiac lesions.
The aim of this study was to detect and quantify T. 
cruzi DNA in tissues of chronic chagasic patients using 
NPCR and real-time PCR methods, respectively. 
PATIENTS, MATERIALS AND METHODS
Patients and samples - The study was approved by 
the Research Ethics Committee of the Faculty of Medi-
cal Sciences, State University of Campinas. DNA sam-
ples isolated from paraffin-embedded tissue sections of 
23 necropsied individuals with positive serologic and/
or pathological tests for Chagas disease were analyzed 
through NPCR amplification. Out of 23 patients, 18 pre-
sented the cardiac form and five presented the cardiodi-
gestive form of Chagas disease. NPCR was performed in 
70 heart tissue samples randomly extracted from sinus 
node, atrium-ventricular region and cardiac septum. We 
also analyzed 56 samples from GIT (esophagus, colon 
and large intestine) (Table I).
The tissues were collected during necropsies con-
ducted between 1986-2005 at the Teaching Hospital of 
the Catholic University of Campinas, which supplied 
the epidemiologic and pathological data on the studied 
cases. In addition to the 126 samples, DNA was isolated 
from 10 paraffin-embedded heart and GIT sections as 
negative controls because the patients presented nega-
tive epidemiology for Chagas disease. To verify the 
DNA quality and the absence of inhibitors, the human 
β-globin gene was amplified by NPCR (Saiki et al. 1985) 
in each sample.
For quantitative assays, only 13 positive NPCR DNA 
samples presented a minimum concentration of DNA to 
be used in real-time PCR as the standardized concentra-
tion for the reaction was 2 ng/µL. Out of 13 samples, 11 
presented cardiac involvement (C1-C11) and two (CD1 
and CD2) presented the cardiodigestive form defined by 
serological and anatomopathological evidence. 
The number of T. cruzi DNA copies determined by 
real-time PCR was used to establish a relationship with 
heart weight in 13 cases. We also compared the number of 
copies found in heart and GIT in 8/13 cases of the cardiac 
form (C1-C6) and cardiodigestive form (CD1 and CD2). 
Quantification in GIT tissues of C7-C11 and CD3-CD5 
was not possible due to the low DNA concentrations. 
DNA extraction - For DNA extraction, the samples 
from paraffin-embedded blocks were sectioned by a 
microtome 12-15 times at a density of 5 µm. A dispos-
able blade was used for each block, avoiding any pos-
sible contamination. The sections were deparaffinized 
with heated xylol, hydrated (by means of successive 95% 
and 75% absolute ethanol baths and distilled water) and 
digested with proteinase K (20 µg/µL) for 72 h at 60ºC. 
After digestion, the DNA was isolated with the Qiagen 
DNeasy Tissue Kit - Uniscience according to the manu-
facturer’s protocol with a final elution volume of 50 µL. 
NPCR - The NPCR was performed as previously de-
scribed by our group (Marcon et al. 2002) with some 
modifications. The first reaction was performed with 
2 µL of the DNA sample, 50 mM of potassium chlo-
ride, 10 mM of Tris-HCl (pH 8.4), 2.5 mM magnesium 
chloride, 2.0 mM of each oligonucleotide (TCZ1 and 
TCZ2 - first reaction; TCZ3 and TCZ4 - second reac-
tion) described in Table II, deoxyribonucleic mixture 
(1 mM) - dNTPs (dATP, dGTP, dCTP; dTTP) and 2.0 U 
of Taq DNA polymerase (Invitrogen) in a final volume 
of 30 µL. For the second reaction, the MgCl2 concentra-
tion was modified to 2.8 mM and a sample of the PCR 
product (0.5-1.0 µL) was re-amplified with the TCZ3 and 
TCZ4 oligonucleotides, which resulted in a fragment of 
149 base pairs (bp) for positive samples.
The amplification runs were performed with an au-
tomatic MJ Research thermocycler. Both reactions were 
preceded by initial denaturation at 94ºC for 5 min and a 
final extension at 72ºC for 7 min. In the first five steps, 
the annealing temperature was at 60ºC and 65ºC in the 
following 25 steps. The amplified fragment of 149 bp 
was separated by electrophoresis on a 2% agarose gel 
stained with ethidium bromide and visualized by ultra-
violet transillumination.
Real-time PCR assay - To perform the absolute 
quantification, standard samples with known amounts 
of DNA were obtained through cloning of the internal 
NPCR fragment from the satellite DNA region of T. cru-
zi Y strain (TCZ3 and TCZ4 primers), resulting in the 
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TABLE I
Patients’ data and nested polymerase chain reaction (NPCR) results in blocks of heart and gastrointestinal tract (GIT)
Necropsy Serology Clinical form Anatomopathological evidences
Heart
tested blocks/
positive NPCR
GIT
tested blocks/
positive NPCR
C1 Positive Cardiopathy Heart = 620 g, myocarditis 2/2 1/1
C2 ND Cardiopathy Heart = 490 g 2/2 2/2
C3 Positive Cardiopathy Heart = 440 g 2/2 2/2
C4 Positive Cardiopathy Heart = 610 g, rosary bead, epycarditis 2/2 2/2
C5 Positive Cardiopathy Heart = 990 g, apical aneurysm, amastigotes nest 6/6 2/2
C6 Positive Cardiopathy Heart = 390 g, dilated cardiomyopathy 2/2 2/2
C7 Positive Cardiopathy Heart = 640 g 6/6 3/1
C8 Positive Cardiopathy Heart = 450 g, myocarditis 2/2 2/2
C9 Positive Cardiopathy Heart = 420 g, rosary bead, epycarditis 2/2 2/2
C10 Positive Cardiopathy Heart = 340 g, apical aneurysm 7/4 3/3
C11 Negative Cardiopathy Heart = 375 g, apical aneurysm 4/2 3/1
C12 Negative Cardiopathy Heart = 350 g, apical aneurysm, myocarditis 2/2 2/2
C13 Negative Cardiopathy Heart = 400 g, amastigotes nest 1/1 2/2
C14 Positive Cardiopathy Hearth = 470 g, apical aneurysm 2/1 2/1
C15 Positive Cardiopathy Heart = 670 g, apical aneurysm, ganglionitis 1/1 3/2
C16 Positive Cardiopathy Heart = 540 g, apical aneurysm 9/7 5/4
C17 Positive Cardiopathy Heart = 580 g, dilated cardiomyopathy 2/2 2/2
C18 Positive Cardiopathy Heart = 565 g, apical aneurysm, 
 dilated cardiomyopathy
2/2 2/2
CD1 Positive Cardiodigestive Heart = 600 g, amastigotes nest, megacolon,  
megaesophagus
3/3 2/2
CD2 Positive Cardiodigestive Heart = 560 g, apical aneurysm,
ganglionitis (esophagus/colon)
2/1 2/2
CD3 Positive Cardiodigestive Heart = 400 g, megaesophagus 3/2 3/3
CD4 Positive Cardiodigestive Cardiopathy, megaesophagus 2/2 2/2
CD5 ND Cardiodigestive Heart = 540 g, megacolon, miocarditis 2/2 5/5
ND: not described.
six point standard curve on a logarithmic scale (Fig. 1B). 
For real-time PCR, we used the Sybr Green Kit, which 
has a fluorescent probe that intercalates into the DNA 
molecule and emits a light signal in each cycle. 
With the optimum concentration (150 nM) of the 
TCZ3 and TCZ4 primers and the dilutions of the cloned 
product, the Ct (Cycle Threshold) vs. sample quantity 
standard curve was obtained. Amplification efficiency 
was obtained with the E = 10(-1/slope) formula, where slope 
corresponds to the straight-line inclination coefficient 
(Pfaffl 2001) given by the Gene Amp® SDS (Applied 
Biosystems) program. 
Real-time PCR was performed in 25-µL reactions, 
with 12.5 µL of the Sybr Green Mix, 6.25 µL of the 
TCZ1 and TCZ2 (150 nM) primers and 6.25 µL the 
DNA sample mix (2ng/µL). The samples were amplified 
in a thermocycler ABI Prism 7500 (Applied Biosystems) 
with the following PCR conditions: first step (2 min at 
50ºC), second step (denaturation for 10 min at 95ºC) and 
40 runs (15 s at 95ºC and 1 min at 60ºC). As an internal 
reaction control, the human β-actin gene was amplified 
in the same amplification cycle for all samples. In each 
amplification step, a non-template control was subjected 
to the reaction to ensure that there was no contamina-
tion. The results were analyzed with the Gene Amp 7500 
Sequence Detector System® Software (Applied Biosys-
tems) showing fluorescence vs. number of cycles.
TABLE II
Primers for Trypanosoma cruzi nested polymerase chain 
reaction and real-time polymerase chain reaction
Primersa Sequences (5’-3’)
TCZ1 (forward) CGAGCTCTTGCCCACACGGGTGCT
TCZ2 (reverse) CCTCCAAGCAGCGGATAGTTCAGG
TCZ3 (forward) TGCTGCASTCGGCTGATCGTTTTCGA
TCZ4 (reverse) CARGSTTGTTTGGTGTCCAGTGTTGTGA
a: sequences described by Moser et al. (1989) and Ochs et al. 
(1996) (GenBank acession AY520036).
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Statistical analysis - In the 13 cases when real-time 
PCR determined the parasitic load in heart tissues, we 
compared the number of T. cruzi DNA copies and heart 
weight of each patient using the Spearman Correlation 
Coefficient. This coefficient varies from -1-1; the values 
that are close to extremes indicate negative or positive 
correlation, respectively, and the values close to zero do 
not indicate correlation (Conover 1980). The software 
used was SAS System for Windows (Statistical Analysis 
System, version 9.1.3 Service Pack 3, SAS Institute Inc, 
2002-2003, Cary, NC, USA).
Fig. 1A: quantitative real-time polymerase chain reaction (PCR) of 
Trypanosoma cruzi DNA in tissues, demonstrating the intercept (Ct) 
and the DNA samples; B: dynamic range of the T. cruzi satellite DNA 
based quantitative PCR. Results are expressed in logCO (log of num-
ber of copies per 2 ng/µL DNA). 
Fig. 2: satellite DNA of Trypanosoma cruzi amplified by nested 
polymerase chain reaction. C+: Y strain of T. cruzi; C-: negative con-
trol; Lanes 1-4: DNA samples of tissues (heart and gastrointestinal 
tract); M: 100 bp DNA ladder; W: reagents with no DNA.
RESuLTS
We considered as positive samples those that pre-
sented the 149-bp amplification product (Fig. 2) ob-
tained from NPCR of the satellite DNA region of T. cru-
zi. From the 18 patients with the cardiac form, a total of 
98 samples (56 from heart tissue and 42 from GIT) were 
randomly analyzed and 83/98 (84.6%) were positive (48 
and 35 from heart and GIT, respectively). Considering 
the five cases of the cardiodigestive form, 26/28 (92.8%) 
samples were positive. In such cases, NPCR was posi-
tive for 12/14 (85.7%) of heart tissue samples and 14/14 
(100%) of GIT samples as shown in Table III. There was 
no T. cruzi DNA amplification in any of the negative 
control samples, showing the specificity of NPCR.
The real-time PCR quantitative method was shown 
to be reliable and easy to handle. The TCZ3 and TCZ4 
primers were standardized at a concentration of 150 nM 
and 2 ng/µL of DNA were used. Reaction efficiency was 
97.6%, calculated by the straight-line inclination coef-
ficient (Pfaffl 2001) with slope = - 3.467778.
To verify the specificity of the technique when us-
ing real-time PCR, every reaction was performed in du-
plicate and compared to the standard curve, originated 
from the TCZ3-TCZ4 fragment diluted in logarithmic 
scale (Fig. 1A, B). The minimum number of copies de-
TABLE III
Results of nested polymerase chain reaction assay in DNA samples of gastrointestinal tract (GIT) and heart tissues
Clinical form
Patients
(n)
Samples studied 
n (%)
GIT positives 
n (%)
Heart positives 
 n (%)
Cardiac 18 83/98 (84.6) 35/42 (83.3) 48/56 (85.7)
Cardiodigestive 5 26/28 (92.8) 14/14 (100) 12/14 (85.7)
Total 23 109/126 (86.5) 49/56 (87.5) 60/70 (85.7)
Negative controls 10 0/20 (0) 0/10 (0) 0/10 (0)
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tected was 3.12 and the maximum was 1965.23 in 2 ng/
µL of DNA. These data were analyzed by the Gene Amp 
7500 Sequence Detector System® Software (Applied 
Biosystems) program. The human β-actin gene was am-
plified in all samples in the same reaction runs to assure 
the quality of tested samples. 
In eight samples assessed by real-time PCR, we com-
pared the number of copies of T. cruzi DNA by QPCR 
between the heart and GIT and found that in cases with 
cardiopathy, the number of copies in the heart was higher 
(3.2-292 times). In the two patients with the cardiodiges-
tive form the difference between the number of copies 
was lower (1.3 and 2.3 times) (Table IV). 
DNA extracted from the 13 heart samples showed there 
was no statistical correlation between the heart weight 
and the number of copies found in this organ or with other 
pathological data (Fig. 3, Table V). Despite the low num-
ber of cases, these data suggest that parasitic loads in the 
affected tissues are not related to organ damage. 
TABLE V
Comparison between number of copies found by quantitative polymerase chain reaction and pathological data
Heart samples Anatomopathological evidences
Copies  
(n) 
C5 -  left ventricule Heart = 990 g, apical aneurysm, amastigotes nest 1770.2
C7 -  left ventricule Heart = 640 g 5.77
C1 - apical tissue Heart = 620 g, myocarditis, myositis 256.23
C4 - left ventricule Heart= 610 g, rosary-bead type epicarditis 395.87
CD1 - sinus node Heart = 600 g, amastigotes nest, megacolon, megaesophagus 33.44
CD2 - right atrium, left ventricule Heart = 560 g, ganglionitis (esophagus and colon), apical aneurysm 11.54
C2 - ventricule Heart = 490 g 283.31
C8 - right atrium Heart = 450 g, myocarditis 1524.05
C3 - left ventricule, apical tissue Heart = 440 g 681.69
C9 - right atrium Heart = 420 g 1965.23
C6 - no described Heart = 390 g, dilated cardiomyopathy 548.1
C10 - no described Heart = 340 g, apical aneurysm 1854.84
CD 3 - bundle of Hiss Heart = 280 g, cardiomyopathy, megaesophagus 3.12
CD1, CD2: heart samples (cardiodigestive form), heart weight in decreasing order. Evaluation of number of copies in 13 heart 
samples and comparison with heart weight; C1-C11: heart samples (cardiac form).
TABLE IV
Number of copies found in cardiac and cardiodigestive  
forms in Chagas disease by quantitative polymerase 
chain reaction (QPCR)
Samples
Copies
(n) Clinical form
CD1- intestine
CD1- sinus node
14.15
33.44
Cardiodigestive
CD2- GIT, no described
CD2- right atrium, left ventricule
8.77
11.54
Cardiodigestive
C1- esophagus
C1- heart, apex
5.74
256.23
Cardiac
C2- colon
C2- ventricule
29.2
283.31
Cardiac
C3- esophagus
C3- left ventriculum, apex
211.22
681.69
Cardiac
C4- colon
C4- left ventricule
12.93
395.87
Cardiac
C5- large intestine
C5- left ventricule
4.75
1770.2
Cardiac
C6- GIT, no descibed
C6- heart, no described
35.45
548.1
Cardiac
results of quantification by QPCR in eight cases comparing 
number of copies between heart and gastrointestinal tract (GIT).
Fig. 3: statistical analysis. Comparison between heart weight and 
number of copies found by real-time polymerase chain reaction. SD: 
standard deviation.
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DISCuSSION
Through NPCR, Ochs et al. (1996) suggested that T. 
cruzi was present in the heart tissues of children who 
died of acute Chagas disease. Significant positive asso-
ciation between parasite persistence in heart tissue and 
myocarditis was demonstrated by PCR in endomyocar-
dial biopsies (Benvenuti et al. 2008). Knowledge of the 
exact role of the parasite in the pathogenesis of Chagas 
disease appears extremely important to guide therapeu-
tic strategies (Higuchi et al. 2003).
The aim of this study was to detect and to quantify 
T. cruzi DNA in tissues of chronic chagasic patients. 
The DNA detection of parasites through NPCR in tis-
sues corroborates previous findings of Cummings and 
Tarleton (2003), showing that T. cruzi is present in target 
organs and may lead to organ damage according to the 
immune response of each individual. The positive rate 
for heart and GIT tissues by NPCR was approximately 
87%, confirming the high sensitivity of the technique, 
even in biological samples obtained from paraffin em-
bedded-tissue sections where the fixation techniques 
lead to DNA loss and folding (Mesquita et al. 2001). 
According to the literature, parasites are rarely found 
in tissues examined by routine staining techniques. 
However, the utilization of highly sensitive molecular 
biology tools, such as PCR, has revealed the presence of 
T. cruzi in involved tissues, but rarely in healthy organs 
of chronic chagasic patients (Ochs et al. 1996, Vago et 
al. 2000). When analysing oesophageal tissue and blood 
samples from chronic chagasic patients with meg-
aoesophagus by PCR and blood cultures, Lages-Silva et 
al. (2001) found that 98% of the samples were positive 
for T. cruzi, confirming the importance of the parasite 
in the host pathological process. In the same study, us-
ing PCR and peroxidase and anti-peroxidase, T. cruzi 
was detected in 76.9% of the analyzed megaoesopha-
gus tissues. In our investigation, this rate was 87.5% 
when GIT fragments were analyzed by NPCR (Table 
III), which indicates the presence of T. cruzi even when 
there was no clinical evidence of digestive commitment 
and only heart involvement.
Using NPCR-based detection of satellite DNA of T. 
cruzi in infected tissues of chagasic patients, the pres-
ence of the parasite may be related to the progression of 
chagasic cardiopathy and/or colonopathy. According to 
a review article by Tarleton (2003), authors that support 
the autoimmunity hypotheses in Chagas disease also ad-
mit that the persistence of the parasite plays an impor-
tant role for the progression of the disease, as proven by 
detection of the parasite DNA, proteins and even of in-
tact parasites in the infected tissues. Zhang and Tarleton 
(1999) demonstrated that parasite persistence in experi-
mental models has absolute correlation with the severity 
of the illness. The detection of T. cruzi DNA in tissues 
by molecular techniques rescues the role of the parasite 
in Chagas disease, as well as the expression of its genes 
over the course of infection (Macedo et al. 2004).
When the number of copies obtained by real-time PCR 
in heart was compared with GIT samples, we observed 
that in cardiopathy cases, the number of molecules found 
was proportionally higher in the heart (3.2-292 times), 
suggesting that the inflammatory process is related to 
the presence of T. cruzi. In the two cases with the car-
diodigestive form, the difference between the numbers 
of copies found was significantly lower. Considering 
that the cardiodigestive form of Chagas disease is less 
frequent than the cardiac form in Brazil, it is difficult 
to obtain samples from the heart and GIT of a single pa-
tient (Vago et al. 2000). There certainly are several host 
immunologic factors and parasite antigens involved in 
the pathogenesis of the chagasic infection. Our findings 
add value to the importance of quantification of T. cruzi 
DNA by QPCR for the study of Chagas disease and may 
be compared, after further investigation, to techniques 
that use inflammatory markers to help understand the 
relationship between parasite loads and organ damage. 
According to Cummings and Tarleton (2003), doubts 
regarding the role of parasites found in tissues need fur-
ther clarification. In our study, there was no significant 
statistical relationship between the heart weight and the 
number of amplified DNA molecules by QPCR (Fig. 3). 
Such results indicate that T. cruzi affects the target organ 
but the parasite loads are variable. However, a tenden-
cy towards an inverse correlation between the number 
of copies and the weight of the heart was noted, which 
might have had statistical significance if the number of 
cases had been higher.
In the current study, the greatest challenge was to 
standardize the DNA concentration at a 2 ng/µL. It is 
known that the isolation of genetic material from par-
affin-embedded tissue sections yields low amounts of 
DNA, which is frequently fragmented, degraded and 
folded with proteins. Due to the low DNA concentration, 
some samples tested by NPCR were not quantified by 
real-time PCR. As genomic DNA was used, including 
human and T. cruzi DNA, we took special care to ampli-
fy β-actin gene in the same PCR cycle, imparting quality 
to the experimental protocol. However, the standardized 
technique requires less time and it presents a lower con-
tamination risk that the NPCR. 
Our data emphasizes that molecular biology tools, 
such as NPCR and real-time PCR, used to detect and 
to quantify DNA extracted from fixed tissues may con-
tribute to a better comprehension of the pathogenesis of 
Chagas disease (Valadares et al. 2008). The difference in 
the number of copies found in different tissues by real-
time PCR indicates that the variability in parasite load is 
associated with pathological alterations in target organs 
as well with disease progression. 
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